Literature DB >> 10914033

Measurement of sphingomyelinase activity.

E Gulbins1, R Kolesnick.   

Abstract

Mesh：

Substances：

Year:  2000        PMID： 10914033     DOI： 10.1016/s0076-6879(00)22036-3

Source DB:  PubMed          Journal:  Methods Enzymol        ISSN： 0076-6879            Impact factor:   1.600


× No keyword cloud information.
  6 in total

Review 1.  Role of sphingolipids in the biogenesis and biological activity of extracellular vesicles.

Authors:  Claudia Verderio; Martina Gabrielli; Paola Giussani
Journal:  J Lipid Res       Date:  2018-05-31       Impact factor: 5.922

2.  Derivatization of common antidepressant drugs increases inhibition of acid sphingomyelinase and reduces induction of phospholipidosis.

Authors:  Cosima Rhein; Stefan Löber; Peter Gmeiner; Erich Gulbins; Philipp Tripal; Johannes Kornhuber
Journal:  J Neural Transm (Vienna)       Date:  2018-09-06       Impact factor: 3.575

3.  Ceramide modulates HERG potassium channel gating by translocation into lipid rafts.

Authors:  Sindura B Ganapathi; Todd E Fox; Mark Kester; Keith S Elmslie
Journal:  Am J Physiol Cell Physiol       Date:  2010-04-07       Impact factor: 4.249

4.  Lysosomal ceramide mediates gemcitabine-induced death of glioma cells.

Authors:  Claudia A Dumitru; Ibrahim E Sandalcioglu; Marek Wagner; Michael Weller; Erich Gulbins
Journal:  J Mol Med (Berl)       Date:  2009-09-10       Impact factor: 4.599

5.  Functional implications of novel human acid sphingomyelinase splice variants.

Authors:  Cosima Rhein; Philipp Tripal; Angela Seebahn; Alice Konrad; Marcel Kramer; Christine Nagel; Jonas Kemper; Jens Bode; Christiane Mühle; Erich Gulbins; Martin Reichel; Cord-Michael Becker; Johannes Kornhuber
Journal:  PLoS One       Date:  2012-04-27       Impact factor: 3.240

6.  Identification of novel functional inhibitors of acid sphingomyelinase.

Authors:  Johannes Kornhuber; Markus Muehlbacher; Stefan Trapp; Stefanie Pechmann; Astrid Friedl; Martin Reichel; Christiane Mühle; Lothar Terfloth; Teja W Groemer; Gudrun M Spitzer; Klaus R Liedl; Erich Gulbins; Philipp Tripal
Journal:  PLoS One       Date:  2011-08-31       Impact factor: 3.240
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.